| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.9B | $1.6B | $1.8B | 17.4% | 3.3% |
| Op. Income | $272M | $190M | $259M | 43.3% | 5.0% |
| Gross Margin | 40.0% | 39.7% | 39.9% | 0.3pp | 0.1pp |
| Net Margin | 10.1% | 6.6% | 9.6% | 3.5pp | 0.5pp |
| EPS (Diluted) | $2.15 | $1.19 | $1.85 | 80.7% | 16.2% |
| Free Cash Flow | $149M | $100M | $160M | 48.1% | -7.5% |
| Item | Amount |
|---|---|
| REVENUE | $1.9B |
| Cost of Revenue | $1.1B |
| GROSS PROFIT | $742M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $471M |
| SG&A Expenses | $470M |
| Other Expenses | $0 |
| Operating Expenses | $470M |
| Cost & Expenses | $1.6B |
| OPERATING INCOME | $272M |
| Interest Income | $0 |
| Interest Expense | $6M |
| Other Income/Expenses | -$19M |
| INCOME BEFORE TAX | $253M |
| Income Tax Expense | $66M |
| Net Income from Continuing Ops | $187M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $187M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $187M |
| D&A | $55M |
| EBIT | $272M |
| EBITDA | $327M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $1.9B |
| Cost of Revenue | $1.1B |
| GROSS PROFIT | $742M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $471M |
| SG&A Expenses | $470M |
| Other Expenses | $0 |
| Operating Expenses | $470M |
| Cost & Expenses | $1.6B |
| OPERATING INCOME | $272M |
| Interest Income | $0 |
| Interest Expense | $6M |
| Other Income/Expenses | -$19M |
| INCOME BEFORE TAX | $253M |
| Income Tax Expense | $66M |
| Net Income from Continuing Ops | $187M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $187M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $187M |
| D&A | $55M |
| EBIT | $272M |
| EBITDA | $327M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $187M |
| Depreciation & Amortization | $55M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | -$51M |
| Other Non-Cash Items | $10M |
| Change in Working Capital | $7M |
| OPERATING CASH FLOW | $208M |
| Capital Expenditure | -$60M |
| Acquisitions (Net) | -$6M |
| Purchases of Investments | -$120M |
| Sales/Maturities of Investments | $112M |
| Other Investing Activities | $6M |
| NET CASH FROM INVESTING | -$68M |
| Net Debt Issuance | -$670.0K |
| Common Stock Repurchased | -$34M |
| Common Dividends Paid | -$22M |
| Other Financing Activities | -$15M |
| NET CASH FROM FINANCING | -$72M |
| FREE CASH FLOW | $149M |
| Net Change in Cash | $68M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.2B |
| Short-Term Investments | $350M |
| Net Receivables | $719M |
| Inventory | $349M |
| Other Current Assets | $73M |
| TOTAL CURRENT ASSETS | $2.7B |
| PP&E (Net) | $1.7B |
| Goodwill | $166M |
| Intangible Assets | $785M |
| Long-Term Investments | $80M |
| Tax Assets | $0 |
| Other Non-Current Assets | $117M |
| TOTAL NON-CURRENT ASSETS | $2.8B |
| TOTAL ASSETS | $5.5B |
| Account Payables | $366M |
| Short-Term Debt | $350M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $113M |
| TOTAL CURRENT LIABILITIES | $1.3B |
| Long-Term Debt | $1.4B |
| Deferred Revenue NC | $96M |
| Deferred Tax Liabilities | $117M |
| Other Non-Current Liabilities | $833M |
| TOTAL NON-CURRENT LIABILITIES | $2.6B |
| TOTAL LIABILITIES | $3.9B |
| Common Stock | $125M |
| Additional Paid-In Capital | $24M |
| Retained Earnings | $1.6B |
| Treasury Stock | -$163M |
| Accum. Other Comp. Income | $2M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.6B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.6B |
| TOTAL LIABILITIES & EQUITY | $5.5B |
| Total Debt | $1.9B |
| Net Debt | $683M |
